Wang Liang-Chao, Wei Wei-Yen, Ho Pei-Chuan, Wu Pei-Yi, Chu Yuan-Ping, Tsai Kuen-Jer
Division of Neurosurgery, Department of Surgery, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
Front Aging Neurosci. 2021 Nov 12;13:741168. doi: 10.3389/fnagi.2021.741168. eCollection 2021.
Ischemic stroke is an important cause of death and disability worldwide. Early reperfusion by thrombolysis or thrombectomy has improved the outcome of acute ischemic stroke. However, the therapeutic window for reperfusion therapy is narrow, and adjuvant therapy for neuroprotection is demanded. Electrical stimulation (ES) has been reported to be neuroprotective in many neurological diseases. In this study, the neuroprotective effect of early somatosensory cortical ES in the acute stage of ischemia/reperfusion injury was evaluated. In this study, the rat model of transient middle cerebral artery occlusion was used to explore the neuroprotective effect and underlying mechanisms of direct primary somatosensory (S1) cortex ES with an electric current of 20 Hz, 2 ms biphasic pulse, 100 μA for 30 min, starting at 30 min after reperfusion. These results showed that S1 cortical ES after reperfusion decreased infarction volume and improved functional outcome. The number of activated microglia, astrocytes, and cleaved caspase-3 positive neurons after ischemia/reperfusion injury were reduced, demonstrating that S1 cortical ES alleviates inflammation and apoptosis. Brain-derived neurotrophic factor (BDNF) and phosphoinositide 3-kinase (PI3K)/Akt/mammalian target of rapamycin (mTOR) signaling pathway were upregulated in the penumbra area, suggesting that BDNF/TrkB signals and their downstream PI3K/Akt signaling pathway play roles in ES-related neuroprotection. This study demonstrates that somatosensory cortical ES soon after reperfusion can attenuate ischemia/reperfusion injury and is a promising adjuvant therapy for thrombolytic treatment after acute ischemic stroke. Advanced techniques and devices for high-definition transcranial direct current stimulation still deserve further development in this regard.
缺血性中风是全球范围内死亡和残疾的重要原因。通过溶栓或取栓进行早期再灌注改善了急性缺血性中风的治疗结果。然而,再灌注治疗的治疗窗很窄,因此需要神经保护辅助治疗。据报道,电刺激(ES)在许多神经系统疾病中具有神经保护作用。在本研究中,评估了早期体感皮层电刺激在缺血/再灌注损伤急性期的神经保护作用。在本研究中,采用短暂性大脑中动脉闭塞大鼠模型,以探索在再灌注后30分钟开始,施加20Hz、2ms双相脉冲、100μA电流持续30分钟的直接初级体感(S1)皮层电刺激的神经保护作用及其潜在机制。这些结果表明,再灌注后S1皮层电刺激可减小梗死体积并改善功能结局。缺血/再灌注损伤后活化的小胶质细胞、星形胶质细胞和裂解的半胱天冬酶-3阳性神经元数量减少,表明S1皮层电刺激减轻了炎症和细胞凋亡。脑源性神经营养因子(BDNF)和磷脂酰肌醇3激酶(PI3K)/蛋白激酶B(Akt)/雷帕霉素哺乳动物靶蛋白(mTOR)信号通路在半暗带区域上调,提示BDNF/酪氨酸激酶受体B(TrkB)信号及其下游PI3K/Akt信号通路在电刺激相关的神经保护中发挥作用。本研究表明,再灌注后不久进行体感皮层电刺激可减轻缺血/再灌注损伤,是急性缺血性中风溶栓治疗后一种有前景的辅助治疗方法。在这方面,用于高清经颅直流电刺激的先进技术和设备仍值得进一步开发。